Obesity and Coronavirus Disease 2019

Overview

Journal J Metab Bariatr Surg

Date 2023 Jan 23

PMID 36687755

Authors

Min-Ji Kim

Jae-Han Jeon

Affiliations

Soon will be listed here.

Abstract

Obesity, which is one of the most important noncommunicable diseases, has become an epidemic. With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, the collision of these two health risks has increased the threat of adverse events and serious threats to public health. In this review, the impact of obesity on COVID-19 severity and mortality is presented. The mechanism by which obesity increases susceptibility and severity is discussed. As a low-grade inflammatory disease, obesity provides a pro-inflammatory milieu by which adipose tissue expressing angiotensin converting enzyme 2, which is known as a receptor for severe acute respiratory syndrome coronavirus 2, works as a viral reservoir. Finally, the role of metabolic and bariatric surgeries during the COVID-19 era will be discussed.

References

Ji W, Lee R, Huh K, Kang M, Hwang I, Radnaabaatar M . Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study. Endocrinol Metab (Seoul). 2021; 36(1):196-200. PMC: 7937843. DOI: 10.3803/EnM.2020.856. View

Jung C, Park H, Kim D, Lim H, Chang J, Choi Y . Association between Body Mass Index and Risk of Coronavirus Disease 2019 (COVID-19): A Nationwide Case-control Study in South Korea. Clin Infect Dis. 2020; 73(7):e1855-e1862. PMC: 7499566. DOI: 10.1093/cid/ciaa1257. View

Yu W, Rohli K, Yang S, Jia P . Impact of obesity on COVID-19 patients. J Diabetes Complications. 2020; 35(3):107817. PMC: 7690270. DOI: 10.1016/j.jdiacomp.2020.107817. View

Sattar N, McInnes I, McMurray J . Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation. 2020; 142(1):4-6. DOI: 10.1161/CIRCULATIONAHA.120.047659. View

Kim S, Yoo D, Min C, Wee J, Kim J, Choi H . Analysis of Mortality and Morbidity in COVID-19 Patients with Obesity Using Clinical Epidemiological Data from the Korean Center for Disease Control & Prevention. Int J Environ Res Public Health. 2020; 17(24). PMC: 7764883. DOI: 10.3390/ijerph17249336. View

Maier H, Lopez R, Sanchez N, Ng S, Gresh L, Ojeda S . Obesity Increases the Duration of Influenza A Virus Shedding in Adults. J Infect Dis. 2018; 218(9):1378-1382. PMC: 6151083. DOI: 10.1093/infdis/jiy370. View

Goyal P, Choi J, Pinheiro L, Schenck E, Chen R, Jabri A . Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020; 382(24):2372-2374. PMC: 7182018. DOI: 10.1056/NEJMc2010419. View

Connors J, Levy J . COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23):2033-2040. PMC: 7273827. DOI: 10.1182/blood.2020006000. View

Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q . Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020; 43(7):1392-1398. DOI: 10.2337/dc20-0576. View

10.

Moriconi D, Masi S, Rebelos E, Virdis A, Manca M, De Marco S . Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obes Res Clin Pract. 2020; 14(3):205-209. PMC: 7269944. DOI: 10.1016/j.orcp.2020.05.009. View

11.

Dugail I, Amri E, Vitale N . High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification. Biochimie. 2020; 179:257-265. PMC: 7340594. DOI: 10.1016/j.biochi.2020.07.001. View

12.

Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z . Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study. Obesity (Silver Spring). 2020; 28(10):1815-1825. PMC: 7361308. DOI: 10.1002/oby.22943. View

13.

Klang E, Kassim G, Soffer S, Freeman R, Levin M, Reich D . Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. Obesity (Silver Spring). 2020; 28(9):1595-1599. PMC: 7283736. DOI: 10.1002/oby.22913. View

14.

Aminian A, Tu C . Association of Bariatric Surgery with Clinical Outcomes of SARS-CoV-2 Infection: a Systematic Review and Meta-analysis in the Initial Phase of COVID-19 Pandemic. Obes Surg. 2021; 31(6):2419-2425. PMC: 7792914. DOI: 10.1007/s11695-020-05213-9. View

15.

Docherty A, Harrison E, Green C, Hardwick H, Pius R, Norman L . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020; 369:m1985. PMC: 7243036. DOI: 10.1136/bmj.m1985. View

16.

Emilsson V, Gudmundsson E, Aspelund T, Jonsson B, Gudjonsson A, Launer L . Serum levels of ACE2 are higher in patients with obesity and diabetes. Obes Sci Pract. 2021; 7(2):239-243. PMC: 8019273. DOI: 10.1002/osp4.472. View

17.

Al-Benna S . Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020; 19:100283. PMC: 7368415. DOI: 10.1016/j.obmed.2020.100283. View

18.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

19.

Uccelli M, Cesana G, De Carli S, Ciccarese F, Oldani A, Zanoni A . COVID-19 and Obesity: Is Bariatric Surgery Protective? Retrospective Analysis on 2145 Patients Undergone Bariatric-Metabolic Surgery from High Volume Center in Italy (Lombardy). Obes Surg. 2020; 31(3):942-948. PMC: 7599117. DOI: 10.1007/s11695-020-05085-z. View

20.

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F . Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. PMC: 7184372. DOI: 10.1093/cid/ciaa415. View